Meeder Asset Management Inc Regeneron Pharmaceuticals, Inc. Put Options Transaction History
Meeder Asset Management Inc
- $1.74 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding REGN
# of Institutions
1,442Shares Held
89MCall Options Held
1.78MPut Options Held
1.75M-
Vanguard Group Inc Valley Forge, PA9.42MShares$6.05 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.42 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.63 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.1 Billion0.1% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.46 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $68.8B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...